Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,288.00
Bid: 2,284.00
Ask: 2,286.00
Change: 14.00 (0.62%)
Spread: 2.00 (0.088%)
Open: 2,278.00
High: 2,298.00
Low: 2,270.00
Prev. Close: 2,274.00
PLUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Sep 2023 07:00

RNS Number : 5251M
Plus500 Limited
15 September 2023
 

 

15 September 2023

 

Plus500 Ltd.

 

("Plus500", the "Company", or together with its subsidiaries, the "Group")

 

Directorate Change

 

Plus500, a global multi‐asset fintech group operating proprietary technology‐based trading platforms, confirms that, having completed her three-year term as an External Director under the provisions of Israel's Companies Law, 5759-1999 ("Companies Law"), following her appointment to the Board by shareholders at the Company's 2020 AGM held on 16 September 2020, Ms. Anne Grim, our Senior Independent Non-Executive Director and External Director is required to step down from the Board of Directors effective as of today.

The Company intends to convene an EGM later in 2023 for the reappointment of Ms. Grim as an independent Non-Executive Director and External Director, in accordance with the provisions of the Companies Law.

The Company also announces today, in accordance with Listing Rule 9.6.11(3), that Prof. Varda Liberman, our Independent Non-Executive Director and Chair of the Regulatory & Risk Committee, will replace Ms. Anne Grim as the Senior Independent Director, with immediate effect.

 

For further details

 

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

Owen Jones, Head of Investor Relations

+972 4 8189503

+44 (0) 7551 654208

ir@Plus500.com

 

Dentons Global Advisors

James Melville-Ross

James Styles

Leah Dudley

 

+44 (0)20 7664 5095

plus500@dentonsglobaladvisors.com

 

 

About Plus500

 

Plus500 is a global multi‐asset fintech group operating proprietary technology‐based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over‐the‐Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures.

The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems (Windows, iOS and Android) and web browsers. Customer care is and has always been integral to Plus500, as such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure and stop losses to help customers protect profits, while limiting capital losses.

Plus500 shares have a premium listing on the Main Market of the London Stock Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index. www.plus500.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANNLFSEDEFA
Date   Source Headline
20th Feb 202312:51 pmRNSTR1: Notification of Major Holdings
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:01 amRNSDirector/PDMR Shareholding
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:01 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSFinal Results
13th Feb 20237:00 amRNSTransaction in Own Shares
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20237:02 amRNSTransaction in Own Shares
6th Feb 20237:00 amRNSPlus500 obtains licence in United Arab Emirates
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20231:34 pmRNSNotification of major holdings
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20237:00 amRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:02 amRNSTransaction in Own Shares
17th Jan 20237:01 amRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSNotification under Listing Rule 9.6.14(2)
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:01 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSYear End Trading Update
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSDirector/PDMR Dealing and Total Voting Rights
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSTransaction in Own Shares
23rd Dec 20227:00 amRNSTransaction in Own Shares
22nd Dec 20227:00 amRNSTransaction in Own Shares
21st Dec 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.